Skip to main content
. 2021 Nov 10;13(Suppl 2):S921–S926. doi: 10.4103/jpbs.jpbs_371_21

Table 3.

Association of the COVID-19 and mortality

Variables Coefficients 95% clearance Significance
Age 0.051 0.02-0.08 0.0005
Men 4.12 1.4-6.90 0.00010
SOB 2.80 1.0-4.61 0.0021
HT 6.97 3.3-10.7 0.0002
DM 7.21 1.4-173.99 0.006
Chills 5.80 2.8-8.91 0.00020
Fatigue 2.50 0.5-4.50 0.01
Pyrexia 2.90 0.2-5.70 0.04
Cough 2.10 0.2-4.11 0.03
Kidney injury 14.40 9.0-19.80 <0.0001
Pneumonia 11.70 5.9-17.50 <0.00010
Malaise 2.70 0.7-4.80 0.0097
Diarrhea 3.40 0.01-6.90 0.051
Heart failure 6.20 2.3-10.11 0.0021
ARDS 6.10 4.5-7.60 <0.0001
Shock 23.30 13.7-32.90 <0.0001
Respiratory failure 2.50 0.4-4.60 0.021
TWBC (g/L) 0.30 0.07-0.60 0.010
ALT (U/L) 0.060 0.01-0.100 0.010
Total bilirubin (µmol/L) 0.20 0.01-0.40 0.040
Lymphocyte count (g/L) −ymph −ymphocyte 0.0010
AST (U/L) 0.030 0.01-0.050 0.002
Albumin (g/L) −lbum −lbumin (g <0.0001
LDH (U/L) 0.010 0.00-0.002 0.007
Procalcitonin (ng/mL) 2.10 0.7-3.50 0.0041
NC (g/L) 0.50 0.3-0.80 <0.0001
Creatinine (μmol/L) 0.030 0.01-0.050 0.0005
CRP (mg/L) 0.040 0.02-0.051 <0.0001
BUN (mmol/L) 0.40 0.09-0.60 0.009
CK (U/L) −K (U/ −K (U/L) 0/L)μ 0.0032
PT (s) 0.40 0.01-0.80 0.041
Antibiotic usage 4.10 2.9-5.40 <0.0001
Corticosteroids usage 4.30 2.6-6.11 <0.0001
IgG 2.60 0.7-6.40 0.010
ICU 4.10 2.0-7.21 ≤0.0001

HT: Hypertension, DM: Diabetes mellitus, CRP: C-reactive protein, SOB: Shortness of breath, ALT: Alanine aminotransferase, TWBC: Total white blood cell counts, AST: Aspartate aminotransferase, LDH: Lactic dehydrogenase, BUN: Blood urea nitrogen, PT: Prothrombin time, IgG: Immunoglobulin G, NC: Neutrophil count, ICU: Intensive care unit, CK: Creatine kinase